Senior executives of traditional Chinese medicine companies leave frequently, and more than 6 "leave" in March

Since March, executives in the pharmaceutical industry have continued to change frequently, and many of them have resigned from senior executives of traditional Chinese medicine companies, including Essence Pharmaceuticals, Qianjin Pharmaceuticals, China Medicines, Jiangzhong Pharmaceuticals, Jinling Pharmaceuticals, and Fangsheng Pharmaceuticals
.
According to the author's incomplete statistics, at least 6 executives of 6 pharmaceutical companies "left" in March
.
As a result, the reasons for leaving are mainly due to personal reasons, and some are due to job adjustment and age reasons
.
Essence Pharma: Supervisor resigns On March 30, Essence Pharma announced that the company's board of supervisors received a written resignation report from supervisor Mr.
Shen Zhigang on March 28, 2022.
Mr.
Shen Zhigang was transferred due to work reasons and had another appointment, and applied for his resignation as a supervisor of the company.

.
After Mr.
Shen Zhigang resigned, he no longer held any positions in the company
.
According to the data, Essence Pharmaceutical is an enterprise mainly engaged in the research and development, production and sales of Chinese patent medicines, APIs, pharmaceutical intermediates and western medicine preparations
.
Qianjin Pharmaceutical: Independent Director Resigns On March 26, Qianjin Pharmaceutical announced that due to personal reasons, Ms.
Deng Jianhua applied to resign as an independent director of the company, and at the same time resigned from her positions in various special committees of the board of directors
.
After resigning, Ms.
Deng Jianhua will no longer hold any position in the company
.
According to the data, Qianjin Pharmaceutical is mainly engaged in the research, development, production and sales of Chinese patent medicines, chemical medicines and feminine hygiene products, as well as the wholesale and retail business of medicines
.
Sinopharm: Regarding the resignation of supervisors On March 24, Sinopharm issued an announcement that due to work adjustment, Mr.
Chen Zheng applied for his resignation as a supervisor of the company and no longer held any positions in the company.
His resignation report will take effect when it is delivered to the board of supervisors
.
Statistics show that China Pharmaceutical has three major business sectors: pharmaceutical industry, pharmaceutical business, and international trade
.
Among them, the pharmaceutical industry mainly involves the R&D and production of chemical preparations, chemical raw materials, biological products, and Chinese patent medicines
.
Jiangzhong Pharmaceutical: General Manager Resigns On March 19, Jiangzhong Pharmaceutical issued an announcement that due to personal age, Mr.
Cai Xinping applied for his resignation as the general manager of the company, and the resignation report took effect from the date it was delivered to the board of directors
.
According to the data, Jiangzhong Pharmaceutical is mainly engaged in the production, research and development and sales of medicines and general health products.
Among them, "Jiangzhong Brand Jianwei Xiaoshi Tablets" is widely known as the company's flagship product
.
Jinling Pharmaceutical: Company Director Resigns On March 10, Jinling Pharmaceutical issued an announcement that Mr.
Qin Fan requested to resign as a director of the company, a member of the Nomination Committee of the Board of Directors, and a member of the Remuneration and Assessment Committee of the Board of Directors due to work needs
.
After his resignation, Mr.
Qin Fan will no longer hold any position in the company, and his resignation report will take effect from the date it is delivered to the board of directors of the company
.
According to the data, Jinling Pharmaceutical's main business is pharmaceutical, medical device manufacturing and medical and health care services
.
Among them, the pharmaceutical business refers to the production and sales of Chinese patent medicines and chemical medicines
.
Fangsheng Pharmaceutical: Chairman and General Manager Resign On March 4, Fangsheng Pharmaceutical announced that due to personal reasons, Mr.
Zhang Qinghua applied for his resignation as the company's chairman (legal representative), director, director of the strategic development committee of the board of directors and General Manager position
.
The resignation report submitted by him will take effect from the date it is delivered to the board of directors of the company.
After resignation, Mr.
Zhang Qinghua will still hold other positions in the company
.
According to the data, Fangsheng Pharmaceutical is an enterprise engaged in the research and development, production and sales of drugs.
The company's main drug categories include cardiovascular and cerebrovascular Chinese patent medicines, orthopedic medicines, pediatric medicines, gynecological medicines, and anti-infectives
.
"Testing and Calibration of Dry Body Temperature Calibrators" is about to be broadcast, welcome to sign up Disclaimer: In any case, the information or opinions expressed in this article do not constitute investment advice to anyone
.